011220 Niacinamide 2% / Spironolactone 5% / Tretinoin 0.05%
Product Images NDC 72934-1207

3 FDA label images from Sincerus Florida, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for 011220 Niacinamide 2% / Spironolactone 5% / Tretinoin 0.05% (NDC 72934-1207). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E (2 End)

E (2 End)
This image shows a drug information label with directions for use, including application instructions and storage conditions. It also provides contact information for Sincerus Florida, LLC in Pompano Beach, Florida, for reporting adverse reactions. There is a QR code at the bottom of the label.*
FDA Label Image

S (1207 2 Front)

S (1207 2 Front)
011220 NIACINAMIDE 2% / SPIRONOLACTONE 5% / TRETINOIN 0.05% gel in a white plastic container with a pump dispenser. The label shows the NDC 72934-1207-2, a 30 gram package size, and the labeler, Sincerus Florida, LLC. The product is noted as a compounded drug made in the USA.*
FDA Label Image

D (1207 2 Middle)

D (1207 2 Middle)
Label panel of 011220 Niacinamide 2%, Spironolactone 5%, Tretinoin 0.05% topical gel by Sincerus Florida, LLC. The label lists active ingredients niacinamide USP 2%, spironolactone USP 5%, tretinoin USP 0.05%, and several inactive ingredients including ascorbyl palmitate FCC, butylated hydroxytoluene NF, glycerin, artificial rose water, sodium metabisulfite NF, and the gel base, totaling 85.4%.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.